FDA Orange Book · active-ingredient family
Rimantadine hydrochloride
Rimantadine hydrochloride is approved as 2 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:FLUMADINE · NDA 019649
2
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · syrup, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FLUMADINERLD | SUN PHARM INDS INC | NDA 019649 | — | Sep 17, 1993 | |
| FLUMADINE | FOREST LABS | NDA 019650 | — | Sep 17, 1993 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| RIMANTADINE HYDROCHLORIDE | CHARTWELL RX | ANDA 076375 | — | Jan 14, 2003 | |
| RIMANTADINE HYDROCHLORIDE | IMPAX LABS | ANDA 076132 | — | Aug 30, 2002 | |
| RIMANTADINE HYDROCHLORIDE | IMPAX LABS INC | ANDA 075916 | — | Nov 02, 2001 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Rimantadine hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

